By Dan Packel, Originally published on Law 360 Pennsylvania plaintiffs should not draw too much hope from the state’s Supreme Court declining to address a lower court ruling that product liability claimsfrom users of generic Reglan weren’t necessarily preempted by federal law, as rulings in other venues have not been kind to claimants… [ Read More ]
By Keith Bradsher and Chris Buckley, Published on The New York Times on September 19th, 2014 HONG KONG — China, a country that has enticed the world’s multinationals to invest billions of dollars over the past decade with the prospect
Employment Law – Supreme court’s DOMA decision affects HIPAA privacy rules, changes to California’s employment law, H-1B cap cases around the corner and more.
Expert article by Pedro Serrano Espelta and Gustavo Luis Morales Oliver. Originally published on marval.com.ar in June 2013. Republished with the permission of Pedro Serrano Espelta. Brazil enacted Law No. 12,489 which sanctions acts of corporate corruption occurring abroad. This new law follows the trend of the US FCPA, the UK Bribery Act, and other…
Expert article by Joseph E. Cwik on April 29, 2014. Originally published on Healthcare Law Insights, reposted with the permission of Joseph E. Cwik. When inter partes review actions first became available in 2012, no generic pharma companies availed themselves to this litigation tool. Not until 2013 did a generic pharma company first seek inter…
Expert article by Pedro Serrano Espelta and Gustavo Luis Morales Oliver. Originally published on marval.com.ar in June 2013. Republished with the permission of Pedro Serrano Espelta. The suspension of the tax ID number is a new element in anti-corruption cases in Argentina and by itself could send a company out of business since a company…
Expert article by Joseph E. Cwik on May 27, 2014. Originally published on Healthcare Law Insights, reposted with the permission of Joseph E. Cwik. Several parts of the America Invents Act (the “AIA”) became law on Sept. 16, 2012, sparking some of the most meaningful changes to patent law seen in decades. One hot provision…
Expert article by Joseph E. Cwik and Josh Nosal on July 2, 2014. Originally published on Healthcare Law Insights, reposted with the permission of Joseph E. Cwik. The Patent Trial and Appeal Board (PTAB) issued its first final written decisions June 20, 2014, in four inter partes reviews (IPR) of pharmaceutical-related patents. The four decisions…
Join Our Mailing List
Receive exclusive discounts, offers and agenda updates directly to your inbox.
We use technologies like cookies to store and/or access device information. We do this to improve browsing experience and to show (non-) personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.